Innocan Pharma Corporation’s $8.2 Million Private Placement

Innocan Pharma Corporation's $8.2 Million Private Placement
Giulia Di Palma
Tagged:

Gowling WLG advised Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF). Innocan Pharma Corporation had closed its private placement of common shares and warrants to purchase…

This content is for Standard 1 Year members only.
Login Join Now
Giulia Di Palma

Author: Giulia Di Palma

…

This content is for Standard 1 Year members only.
Login Join Now